217 filings
Page 3 of 11
8-K
zoh 2n33cvbsh6
28 Jul 22
Novocure Reports Second Quarter 2022 Financial Results
7:03am
8-K
ysuruttug 85
10 Jun 22
Departure of Directors or Certain Officers
4:15pm
8-K
k1sxn9qagdpxu4vgbqo
3 Jun 22
Regulation FD Disclosure
8:01am
8-K
id4f9px gu
26 May 22
Entry into a Material Definitive Agreement
8:04am
8-K
lh5nln vltooy7m0
28 Apr 22
Novocure Reports First Quarter 2022 Financial Results
7:04am
DEFA14A
q50hs0 5d
25 Apr 22
Additional proxy soliciting materials
4:16pm
8-K
dg6 v2a1nui2jw
13 Apr 22
Departure of Directors or Certain Officers
4:06pm
8-K
rvd69w 0qs
7 Apr 22
Other Events
4:07pm
8-K
6z1ulsk4vhs
23 Mar 22
Novocure Announces Favorable Recommendation to Continue the Phase 3 Pivotal INNOVATE-3 Study of Tumor Treating Fields in Ovarian Cancer
8:01am
S-8
pbm1g6ly9s6e8rb bj5
24 Feb 22
Registration of securities for employees
4:03pm
8-K
3dd8y7k5 5qx3jkcre
24 Feb 22
Novocure Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Company Update
7:00am
8-K
028f4hp2l 0mfkep
10 Jan 22
Novocure Announces Preliminary Full Year and Fourth Quarter 2021 Net Revenues and Provides Company Update
7:05am
8-K
ubt4 y4os7dwmkp6i
30 Dec 21
Other Events
4:05pm
8-K
cvhdz7lb79w
7 Dec 21
Novocure Signs Agreement to Acquire and Construct Building in Downtown Portsmouth, New Hampshire
4:01pm